You are here

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients

Last updated on February 22, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Mesa, Arizona, 85206 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pneumonia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Patients with clinical evidence of mild to moderate community-acquired pneumonia, including
cough productive of sputum and a diagnosis of pneumonia, were included.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

Key exclusion criteria were treatment with any systemic antibiotic of greater than one dose
or one combination dose within the previous 7 days, previously diagnosed conditions which
tend to mimic or complicate the course and the evaluation of the evaluation process (e.g.,
bronchiectasis, lung abscess or empyema, active tuberculosis, pulmonary malignancy, cystic
fibrosis, post-obstructive pneumonia), hospitalization in the previous 14 days or infection
acquired in the hospital, and residents of a long-term care facility.

NCT00643734
Pfizer
Completed
A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Community-Acquired Pneumonia
NCT00140023
All Genders
18+
Years
Multiple Sites
Pneumococcal Vaccine, Streptococcus Pneumoniae
NCT01521897
All Genders
0+
Years
Kasuga, Fukuoka
Pneumonia
NCT00137007
All Genders

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now